The CMU Portugal Patient Innovation Accelerator Program inaugural edition concluded with an in-person two-day workshop on June 5th and 6th at Nova Medical School. The event aimed to provide tailored feedback to each Patient Innovation (PI) Bootcamp team on their commercialization roadmaps, helping them refine strategies, validate assumptions, and identify critical next steps.
Throughout these two days, the workshop featured one-on-one Entrepreneur-in-Residence (EIR) sessions, interactive roadmap critiques, and a final round of team presentations highlighting key milestones and challenges. The teams showcased their progress to entrepreneurs and stakeholders, where they discussed commercialization roadmaps and identified risk mitigation and capital efficiency strategies. Panel discussions were designed to define their next steps: commercialization, regulatory pathways, advisory roles, and international partnerships.
The final session was a Q&A featuring Meredith Meyer Grelli, Director of the Project Olympus, along with Max Fedor and Laura Ohlund, Entrepreneur in Residence and domain experts from the Swartz Center for Entrepreneurship. In their presentation, they shared their university and regional ecosystem vision with the participating teams and engaged with participants’ questions.
The workshop concluded with a guided visit to NOVA Medical School’s facilities and a networking lunch, celebrating a shared commitment to innovation and international collaboration.
Photos: Patient Innovation
Back in April, the participating teams took part in a week-long residency at Carnegie Mellon, hosted by Project Olympus and AlphaLab Health, for the Phase II of the program.
More information about the CMU Portugal Patient Innovation Accelerator Program here.
